A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol A
Clinical trial NCT03316300 · COMPLETED
Trial details
- NCT number
- NCT03316300
- Sponsor
- Neurotech Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-24
- Primary completion
- 2022-08-31
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.